CYTK
CYTK
US23282W6057
Cytokinetics, Incorporated
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 88.039.000 18.474.000
376.6%
Cost of Revenue 416.026.000 339.408.000
22.6%
Gross Profit -327.987.000 -320.934.000
2.2%
700.297.000 554.722.000
26.2%
Operating Income -612.258.000 -536.248.000
14.2%
Pretax Income -784.955.000 -589.526.000
33.2%
Net Income Common Stockholders -784.955.000 -589.526.000
33.2%
-- --
--
-- --
--
ende